Associate Professor Barry Slobedman
|
Associate Professor
D06 - Blackburn Building |
|
On this page
Themes | Biographical details | Research interests | Grants | PhD & Masters' project opportunities | Honours project opportunities | Keywords
Biographical details
Associate Professor Barry Slobedman obtained both a BSc (with Honours) and a PhD in molecular virology from the University of Adelaide before moving to Stanford University (USA) where he trained as a post-doctoral research fellow at the Stanford University Medical Center in the Department of Microbiology and Immunology. He returned to Australia as a Rolf Edgar Lake Fellow and established an independent research group in 2000. [More...]
Research interests
Associate Professor Barry Slobedman is head of the Cytomegalovirus (CMV) Research Group. Human CMV is a herpesvirus which infects a vast majority of the worlds population, where it is a leading cause of opportunistic and congenital disease. Primary productive infection leads to a lifelong latent infection that is characterised by maintenance of the viral genome without infectious virus production. Periodically, the virus reactivates from latency and is shed in bodily secretions. Whilst primary and reactivated infections are usually mild or asymptomatic in healthy adults, primary infection is a major cause of serious congenital infection leading to still birth or neurological damage in children and reactivated infection is a major cause of life-threatening disease in immunosuppressed individuals, such as those with HIV AIDS and in allogeneic stem cell and solid organ transplant recipients.
The overall goal of the CMV Research Group is to define the mechanisms by which CMV causes life-threatening disease in these at-risk individuals, so as to provide a rational basis for the design of novel anti-viral therapeutics to prevent or treat CMV disease. The CMV Research Group consists of Postdocs as well as PhD and Honours students and positions are frequently available for those with a keen interest in biomedical research.
Current national competitive grants*
2012
Defining a virally-encoded molecular switch between productive and latent phases of human cytomegalovirus infection.
Slobedman B, Miller W, Mocarski E
NHMRC Project Grants ($326,175 over 3 years)
2011
Human cytomegalovirus encoded control of the latent phase of infection
Slobedman B, Mocarski E, Abendroth A
National Health and Medical Research Council Project Grant ($616,315 over 3 years)
The role of varicella zoster virus in modulating cutaneous infection
Abendroth A, Arvin A, Slobedman B
National Health and Medical Research Council Project Grant ($536,706 over 3 years)
* Grants administered through the University of Sydney
PhD and Masters' project opportunities
Discovering how human cytomegalovirus functions during the latent phase of infection
Honours project opportunities
How does human cytomegalovirus cause life-threatening disease in transplant recipients?
